News
BAYRY
10.29
+0.49%
0.05
CNS Pharmaceuticals Appoints Rami Levin as CEO
Reuters · 1d ago
Bayer's Bemdaneprocel Cell Therapy Wins Sakigake Designation in Japan
Reuters · 1d ago
Bayer price target raised to EUR 41 from EUR 30.40 at Berenberg
TipRanks · 3d ago
Weekly Report: what happened at BAYRY last week (1208-1212)?
Weekly Report · 3d ago
Berenberg Bank Sticks to Their Hold Rating for Bayer (BAYRY)
TipRanks · 3d ago
Bayer (0P6S) Receives a Buy from Kepler Capital
TipRanks · 5d ago
Bayer: Is This The Turning Point Investors Have Been Waiting For?
Seeking Alpha · 5d ago
Bristol Myers Squibb upgraded at Guggenheim on 2026 pipeline catalysts
Seeking Alpha · 6d ago
EMA Panel Recommends EU Approval of Bayer's Aflibercept 8 mg for Retinal Vein Occlusion
Reuters · 6d ago
Bayer (0P6S) Gets a Hold from Berenberg Bank
TipRanks · 6d ago
Bayer price target raised to EUR 40 from EUR 34 at HSBC
TipRanks · 12/10 11:15
ValuEngine Weekly Market Summary And Commentary
Seeking Alpha · 12/09 08:45
Bayer AG’s AskBio Wins Japan SAKIGAKE Designation for Gene Therapies
Reuters · 12/09 07:33
Bayer upgraded to Overweight from Neutral at JPMorgan
TipRanks · 12/08 09:40
Weekly Report: what happened at BAYRY last week (1201-1205)?
Weekly Report · 12/08 09:40
Positive Report for Bayer (0P6S) from J.P. Morgan
TipRanks · 12/08 07:35
Bayer Aktiengesellschaft - Depositary Receipt (BAYRY) Price Target Decreased by 11.29% to 8.03
NASDAQ · 12/06 11:22
Goldman Sachs Group Increases Total Voting Rights in Bayer AG to 5.41%
Reuters · 12/05 09:34
Santen and Bayer Secure NHI Listing for Aflibercept Injection Kit in Japan
Reuters · 12/05 06:35
Cathie Wood's Buys And Rumors Aside, Here's Why Crispr Therapeutics Is A Strong Buy
Seeking Alpha · 12/04 15:29
More
Webull provides a variety of real-time BAYRY stock news. You can receive the latest news about Bayer Aktien through multiple platforms. This information may help you make smarter investment decisions.
About BAYRY
Bayer AG is a German-based life science company. The Company's segments are Crop Science, Pharmaceuticals and Consumer Health. The Crop Science segment focuses on development, production and marketing of products in seeds and plant traits, crop protection, digital solutions and customer services to promote sustainable agriculture. The Pharmaceuticals segment focuses on prescription products, especially for cardiology and women's healthcare and specialty therapeutics focused on the areas of cardiology, oncology, hematology and ophthalmology, as well as gene therapy and others. The Consumer Health segment develops, produces and markets nonprescription over-the-counter medicines for self-medication. Its Consumer Health segment portfolio consists of products in dermatology, nutritional supplements, digestive health, allergy, cough and cold, and pain and cardiovascular risk prevention categories.